Bajaj Health Reports Strong Q3 2025 Growth: Net Sales Up 31.3%, Profit Jumps 33.72%

• Bajaj Health's standalone net sales reached Rs 161.22 crore in December 2025, marking a 31.3% year-over-year increase.
• Quarterly net profit for December 2025 stood at Rs 15.67 crore, a significant 33.72% rise compared to December 2024.
• EBITDA for the quarter increased by 34.65% to Rs 32.33 crore in December 2025.
• Earnings Per Share (EPS) for Bajaj Health grew to Rs 4.96 in December 2025 from Rs 3.65 in December 2024.
• Despite strong quarterly results, Bajaj Health shares closed at Rs 391.80 on January 16, 2026, showing negative returns of -24.57% over 6 months and -39.58% over 12 months.

Why It Matters: Bajaj Health demonstrated robust financial performance in Q3 2025 with significant growth in sales and profit.